It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and ...
SolarWinds Q1 revenue up 4% to $193.31M, topping forecasts; adjusted EPS of $0.29 beats $0.22 estimate. Subscription revenue jumps 26.5% to $68.76M; adjusted EBITDA margin rises sharply by 600 bps to ...
The BioWorld Drug Developers Index underperformed both the Nasdaq Biotechnology Index (NBI) and the Dow Jones Industrial Average (DJIA) throughout February and March. However, it showed some recovery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results